Pepticom set to develop AI models enabling peptide-based drug discovery 24-Oct-2019 By Vassia Barba Pepticom’s technology aims to ‘vastly reduce’ risk of failure in peptide drug candidates’ discovery and development, by utilizing artificial intelligence models.